Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study

Overview of attention for article published in BMC Gastroenterology, December 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 public wall post.

Phase 4, prospective study looking at switching from Entecavir to Tenofovoir (TDF) for people with HBeAg-positive chronic…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.